Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder'
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00007068.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy of vortioxetine (5, 10, and 20 mg)
versus placebo during the first 28 weeks of the 32-week double-blind treatment period in the
prevention of relapse in participants with MDD who responded to acute treatment with
vortioxetine 10 mg.
提供机构：
Vivli
创建时间：
2023-03-27
